Assenagon Asset Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
2,857,904
+2,520,941
| +748% | +$9.23M | 0.02% | 429 |
|
|
2025
Q1 | $1.46M | Sell |
336,963
-2,613,886
| -89% | -$11.3M | ﹤0.01% | 802 |
|
|
2024
Q4 | $9.44M | Buy |
2,950,849
+1,035,120
| +54% | +$3.31M | 0.02% | 508 |
|
|
2024
Q3 | $5.48M | Sell |
1,915,729
-2,061,395
| -52% | -$5.9M | 0.01% | 678 |
|
|
2024
Q2 | $11.1M | Buy |
3,977,124
+3,005,450
| +309% | +$8.42M | 0.02% | 392 |
|
|
2024
Q1 | $2.76M | Hold |
971,674
| – | – | 0.01% | 742 |
|
|
2023
Q4 | $3.97M | Hold |
971,674
| – | – | 0.01% | 674 |
|
|
2023
Q3 | $3.09M | Sell |
971,674
-393,523
| -29% | -$1.25M | 0.01% | 679 |
|
|
2023
Q2 | $4.53M | Hold |
1,365,197
| – | – | 0.02% | 504 |
|
|
2023
Q1 | $2.91M | Sell |
1,365,197
-74,843
| -5% | -$159K | 0.01% | 696 |
|
|
2022
Q4 | $3.87M | Sell |
1,440,040
-570,407
| -28% | -$1.53M | 0.01% | 567 |
|
|
2022
Q3 | $6.51M | Buy |
2,010,447
+7,120
| +0.4% | +$23.1K | 0.03% | 406 |
|
|
2022
Q2 | $9.78M | Buy |
2,003,327
+352,685
| +21% | +$1.72M | 0.04% | 348 |
|
|
2022
Q1 | $12.6M | Buy |
1,650,642
+380,389
| +30% | +$2.9M | 0.03% | 288 |
|
|
2021
Q4 | $11.7M | Buy |
1,270,253
+140,051
| +12% | +$1.29M | 0.03% | 267 |
|
|
2021
Q3 | $16.1M | Buy |
1,130,202
+226,137
| +25% | +$3.22M | 0.05% | 197 |
|
|
2021
Q2 | $15M | Buy |
904,065
+1,360
| +0.2% | +$22.6K | 0.05% | 239 |
|
|
2021
Q1 | $16.4M | Buy |
+902,705
| New | +$16.4M | 0.07% | 219 |
|
|
2019
Q3 | – | Sell |
-17,341
| Closed | -$132K | – | 972 |
|
|
2019
Q2 | $132K | Buy |
+17,341
| New | +$132K | ﹤0.01% | 923 |
|